Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you

recruiting
3 987
countries
28
conditions
2 109

13 trials match your criteria

Depression+1

Recruiting

Efficacy of high- and low-dose psilocybin in preventing relapse in adults with severe alcohol use disorder and depressive symptoms after detoxification

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Depression

Recruiting

Study on Psilocybin, Ketamine, and Midazolam for Treating Depression in Cancer Patients

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam

Palliative care+1

Recruiting

Study of psilocybin therapy for psychological distress in patients with COPD, ALS, multiple sclerosis, or atypical Parkinson's disorders

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Myocardial ischaemia

Recruiting

Study on Psilocybin and Midazolam for Reducing Atherosclerosis in Patients with Coronary Artery Disease

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam

Major depression

Recruiting

Study on Psilocybin for Treating Depression in Cancer Patients

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Major depression

Not yet recruiting

Psilocybin and pimavanserin for adults with major depressive disorder

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Depression

Not yet recruiting

Study of Psilocybin for Patients with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Depression

Not recruiting

Study on Psilocybin for Patients with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Psilocybine

Major depression

Not recruiting

Study on Psilocybin, Ketamine, and Midazolam for Patients with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Midazolam

Seizure+1

Not recruiting

Study on the Effects of Psilocybin for Patients with Psychogenic Non-Epileptic Seizures (PNES)

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Psilocybine

Major depression

Not recruiting

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.